mArilLionpHarmA.com
About mArilLionpHarmA.com
Marillion Pharmaceuticals is a clinical-stage pharmaceuticals company focused on the development and commercialization of novel therapeutics for the treatment of cancers and for supportive care in oncology. Marillion’s product pipeline includes Lu-AMBA, Pilobuc™ and MN-201. Lu-AMBA is a first-in-class receptor targeted therapeutic agent for the treatment of hormone resistant prostate cancer, advanced metastatic breast cancers and non-small cell lung cancers.
